Log in or Sign up for Free to view tailored content for your specialty!
Gynecology/Obstetrics News
Prevalence of pregestational diabetes increased since 2000, increases pregnancy risks
From 2000 to 2019, the prevalence of type 2 diabetes quadrupled, increasing the overall prevalence of pregestational diabetes. The rise in pregestational diabetes increased the odds of adverse pregnancy outcomes, researchers reported.
Q&A: Advancing maternal age and role of prenatal genetic testing
The mean maternal age at first birth has been increasing in the United States in recent years, from 24.9 years in 2000 to 27 years in 2019, according to two CDC reports.
Log in or Sign up for Free to view tailored content for your specialty!
Postpartum visit attendance dropped in first months of COVID-19 pandemic
During the first 9 months of the COVID-19 pandemic, attendance at postpartum visits fell by 5.8 percentage points, according to a research letter published in Obstetrics & Gynecology.
No difference in 1-year usage, pregnancy rates between hormonal, copper IUD users
Pregnancy rates and continued use of IUDs at 1 year after placement were similar between people using levonorgestrel and copper IUDs, according to data published in the American Journal of Obstetrics & Gynecology.
Symptomatic COVID-19 in first two trimesters associated with still, preterm birth risks
Among pregnant women with symptomatic COVID-19, SARS-CoV-2 infection during the first and second trimesters was associated with greater risks for stillbirth and preterm birth compared with infection during the third trimester, data show.
Lifelong access to antiretrovirals nearly eliminates risk for vertical HIV transmission
In Tanzania, pregnant women with HIV who had access to antiretroviral therapy for life had less than a 2% risk for vertical transmission, according to data published in The Lancet HIV.
Cervical cancer screening decreased among older women but may remain higher than needed
Despite decreases in cervical cancer screenings between 1999 and 2019 among older women with Medicare fee-for-service coverage, this group may be overspending on screening-related services, according to data in JAMA Internal Medicine.
Q&A: Survey supports OTC progestin-only pill availability to increase contraceptive access
Over-the-counter progestin-only pills may provide the benefits of other contraceptives while eliminating substantial barriers to access, according to a survey of participants in a study of OTC progestin-only pills.
Q&A: ‘Fighter for the underserved’ sees shifts in family planning access over 60 years
The recent U.S. Supreme Court ruling overturning federal protection for abortion access is just one of several pivotal legal moves affecting access to contraception and infertility care and the right to privacy underpinning this access.
FDA approves second indication for ibrexafungerp in recurrent vulvovaginal candidiasis
The FDA approved ibrexafungerp, an oral, non-azole antifungal drug, for reducing the number of recurrent vulvovaginal candidiasis incidences, according to a press release.